InsiderTrades

Form 4 for LH Labcorp

Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0001127602-24-003550 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-06 2024-02-02 LH Schechter Adam H Pres, CEO, Dir F - Tax $221.54 -822 49.2K -2% -$182.1K
D 2024-02-06 2024-02-02 LH Schechter Adam H Pres, CEO, Dir M - OptEx — +3,094 50.0K +7% —
D 2024-02-06 2024-02-02 LH Schechter Adam H Pres, CEO, Dir M - OptEx $0.00 -3,094 88.1K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-02 F D 822 $221.54 49,160 D — —
2 Common Common Stock 2024-02-02 M A 3,094 — 49,982 D — — (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
3 Derivative Restricted Stock Unit 2024-02-02 M D 3,094 $0.00 88,111 D — · — to — 3,094 Common Stock (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 1,364 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F3) The Restricted Stock Units vested in three equal annual installments beginning on February 2, 2022 and are now fully vested.